SCHEMBL2804101

SCHEMBL2804101

CCN(CC)CCCCCNc1ncc2c(n1)-c1ccccc1C(c1ccccc1)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 14/20 0.51
FGFR2 P21802 6/20 0.51
CACNA2D1 P54289 1/20 0.40
EGFR P00533 4/20 0.40
FGFR3 P22607 5/20 0.39
CSF1R P07333 1/20 0.39
KDR P35968 2/20 0.38
FGFR4 P22455 4/20 0.38
SRC P12931 3/20 0.38
SLC6A4 P31645 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
PRKD3 O94806 1/20 0.37
PRKCG P05129 1/20 0.37
PRKCB P05771 1/20 0.37
PRKCA P17252 1/20 0.37
PRKCH P24723 1/20 0.37
PRKCI P41743 1/20 0.37
PRKCE Q02156 1/20 0.37
PRKCQ Q04759 1/20 0.37
PRKCZ Q05513 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2803180 0.96 FGFR1 (0.53) FGFR1FGFR2CACNA2D1EGFRFGFR3
SCHEMBL2803900 0.89 FGFR1 (0.54) FGFR1FGFR2FGFR3CSF1RHRH3
SCHEMBL2804584 0.89 FGFR1 (0.44) FGFR1FGFR2EGFRFGFR3CSF1R
SCHEMBL2802959 0.89 FGFR1 (0.44) FGFR1FGFR2EGFRFGFR3CSF1R
SCHEMBL2802801 0.88 FGFR1 (0.43) FGFR1FGFR2EGFRFGFR3KDR
SCHEMBL2805147 0.86 FGFR1 (0.55) FGFR1FGFR2FGFR3CSF1RKDM4E
SCHEMBL14644911 0.86 FGFR1 (0.57) FGFR1FGFR2EGFRFGFR3CSF1R
SCHEMBL2804796 0.85 FGFR1 (0.49) FGFR1FGFR2EGFRFGFR3CSF1R
SCHEMBL2807729 0.85 FGFR1 (0.60) FGFR1FGFR2FGFR3CSF1RKDR
SCHEMBL2802737 0.84 FGFR1 (0.48) FGFR1FGFR2EGFRFGFR3CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885CACNA2D1 4499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.